Alice Vitoria Frota Reis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alice Vitoria Frota Reis has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Josimar Oliveira Eloy
Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza 60430-355, CE, Brazil
3 shared publications - Raquel Petrilli
Universidade Federal do Ceará image/svg+xml
2 shared publications - Alex Bruno Matos de França
Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza 60430-355, CE, Brazil
1 shared publication - Andreza de Aguiar Silva
Laboratory of Biotechnology and Reproductive Physiology, Federal University of Ceará, Sobral, Brazil
1 shared publication - Bianca Régia Silva
State University of Ceará - UECE, Fortaleza, Brazil
1 shared publication - Danisvânia Ripardo Nascimento
Laboratory of Biotechnology and Reproductive Physiology, Federal University of Ceará, Sobral, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (2) , 21
Metal and Metal-Containing Nanoparticles Applied to Photodynamic Therapy for Wound Healing
Wounds, particularly chronic wounds, represent an increasing challenge for global health systems, affecting millions of people worldwide, and are often associated with persistent infections, biofilms, and multidrug-resistant microorganisms (MDRMs). In this context, the search for effective therapeutic alternatives has driven interest in photodynamic therapy (PDT), an approach in which light-excited photosensitizers promote the generation of reactive oxygen species (ROS) with antimicrobial and wound healing properties. Although first- and second-generation organic photosensitizers are widely used, they have significant limitations, including low aqueous solubility, self-aggregation, reduced photostability, and unsatisfactory ROS quantum yields. To overcome these drawbacks, various nanotechnology-based strategies have been explored. Among them, metallic nanoparticles stand out because they serve as carriers and exhibit intrinsic photosensitizing activity, high resistance to photobleaching, and remarkable extinction coefficients, which favor efficient singlet oxygen generation. Furthermore, metals such as gold and silver can enhance the performance of organic photosensitizers through a process known as metal-enhanced singlet oxygen generation, whereas others, such as copper, zinc, manganese, and magnesium, actively participate in biochemical events associated with the inflammatory and regenerative phases of wound healing. Considering these advances, this review compiles evidence published over the past five years regarding the use of metallic or metal-containing nanoparticles in PDT for acute and chronic wounds, with an emphasis on in vivo studies. In addition, we discuss the epidemiological and pathophysiological aspects of wounds and the intrinsic wound healing and antimicrobial properties of metallic compounds, thereby providing an integrated and up-to-date perspective.
- 1 April 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (2) , 21
Open AccessMetal and Metal-Containing Nanoparticles Applied to Photodynamic Therapy for Wound Healing
Wounds, particularly chronic wounds, represent an increasing challenge for global health systems, affecting millions of people worldwide, and are often associated with persistent infections, biofilms, and multidrug-resistant microorganisms (MDRMs). In this context, the search for effective therapeutic alternatives has driven interest in photodynamic therapy (PDT), an approach in which light-excited photosensitizers promote the generation of reactive oxygen species (ROS) with antimicrobial and wound healing properties. Although first- and second-generation organic photosensitizers are widely used, they have significant limitations, including low aqueous solubility, self-aggregation, reduced photostability, and unsatisfactory ROS quantum yields. To overcome these drawbacks, various nanotechnology-based strategies have been explored. Among them, metallic nanoparticles stand out because they serve as carriers and exhibit intrinsic photosensitizing activity, high resistance to photobleaching, and remarkable extinction coefficients, which favor efficient singlet oxygen generation. Furthermore, metals such as gold and silver can enhance the performance of organic photosensitizers through a process known as metal-enhanced singlet oxygen generation, whereas others, such as copper, zinc, manganese, and magnesium, actively participate in biochemical events associated with the inflammatory and regenerative phases of wound healing. Considering these advances, this review compiles evidence published over the past five years regarding the use of metallic or metal-containing nanoparticles in PDT for acute and chronic wounds, with an emphasis on in vivo studies. In addition, we discuss the epidemiological and pathophysiological aspects of wounds and the intrinsic wound healing and antimicrobial properties of metallic compounds, thereby providing an integrated and up-to-date perspective.
- Open Access
- 17 March 2026
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 43 (5) , 1605-1620
Decellularized ovarian bioscaffolds and resveratrol-loaded polymeric nanoparticles support in vitro viability and ultrastructural preservation of bovine preantral follicles
Purpose: This study evaluated the effects of decellularized ovarian bioscaffolds and resveratrol-loaded polymeric nanoparticles (RLPN) on the in vitro culture, viability, and ultrastructural preservation of bovine secondary follicles. Methods: Decellularized extracellular matrix (dECM) from cortical fragments was obtained by freeze–thaw cycles and sequential incubation in Triton X-100 and sodium dodecyl sulfate. Decellularization efficiency and extracellular matrix integrity were assessed by hematoxylin–eosin, Hoechst staining, scanning electron microscopy, and quantification of collagen and glycosaminoglycans. Bovine secondary follicles were isolated and cultured for 12 days in either a two-dimensional (2D) system or in dECM scaffolds in medium supplemented with 0.02, 0.2, or 2.0 µM RLNP, blank nanoparticles, or unencapsulated resveratrol. Follicular viability and ultrastructure were evaluated by calcein-AM/ethidium homodimer-1 staining and transmission electron microscopy. Expression of mRNA for catalase, superoxide dismutase, glutathione peroxidase 1, peroxiredoxin 6, and nuclear factor erythroid 2-related factor 2 was assessed by qRT-PCR. Quantitative data were analyzed by unpaired t-tests or one-way ANOVA, followed by Tukey’s test ( P < 0.05). Results: Hematoxylin–eosin and Hoechst staining confirmed effective cell removal, while collagen, glycosaminoglycans, and ECM ultrastructure were preserved. Follicles cultured in the three-dimensional (3D) system showed increased viability, further enhanced by 0.02 or 2.00 µM RLPN. Follicles cultured with 0.02 µM RLPN exhibited well-preserved morphology, including intact zona pellucida, oocyte membrane, and organelles. qRT-PCR analysis revealed reduced mRNA expression of antioxidant-related genes in follicles cultured with RLNP. Conclusion: The decellularization protocol effectively removed cellular content and preserved ECM structure and ultrastructure. 3D culture system combined with supplementation of 0.02 µM RLNP supported follicular viability and ultrastructural preservation and was associated with transcriptional changes in antioxidant-related genes.
- 17 March 2026
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 43 (5) , 1605-1620
Open AccessDecellularized ovarian bioscaffolds and resveratrol-loaded polymeric nanoparticles support in vitro viability and ultrastructural preservation of bovine preantral follicles
Purpose: This study evaluated the effects of decellularized ovarian bioscaffolds and resveratrol-loaded polymeric nanoparticles (RLPN) on the in vitro culture, viability, and ultrastructural preservation of bovine secondary follicles. Methods: Decellularized extracellular matrix (dECM) from cortical fragments was obtained by freeze–thaw cycles and sequential incubation in Triton X-100 and sodium dodecyl sulfate. Decellularization efficiency and extracellular matrix integrity were assessed by hematoxylin–eosin, Hoechst staining, scanning electron microscopy, and quantification of collagen and glycosaminoglycans. Bovine secondary follicles were isolated and cultured for 12 days in either a two-dimensional (2D) system or in dECM scaffolds in medium supplemented with 0.02, 0.2, or 2.0 µM RLNP, blank nanoparticles, or unencapsulated resveratrol. Follicular viability and ultrastructure were evaluated by calcein-AM/ethidium homodimer-1 staining and transmission electron microscopy. Expression of mRNA for catalase, superoxide dismutase, glutathione peroxidase 1, peroxiredoxin 6, and nuclear factor erythroid 2-related factor 2 was assessed by qRT-PCR. Quantitative data were analyzed by unpaired t-tests or one-way ANOVA, followed by Tukey’s test ( P < 0.05). Results: Hematoxylin–eosin and Hoechst staining confirmed effective cell removal, while collagen, glycosaminoglycans, and ECM ultrastructure were preserved. Follicles cultured in the three-dimensional (3D) system showed increased viability, further enhanced by 0.02 or 2.00 µM RLPN. Follicles cultured with 0.02 µM RLPN exhibited well-preserved morphology, including intact zona pellucida, oocyte membrane, and organelles. qRT-PCR analysis revealed reduced mRNA expression of antioxidant-related genes in follicles cultured with RLNP. Conclusion: The decellularization protocol effectively removed cellular content and preserved ECM structure and ultrastructure. 3D culture system combined with supplementation of 0.02 µM RLNP supported follicular viability and ultrastructural preservation and was associated with transcriptional changes in antioxidant-related genes.
- Open Access
- 29 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1371
Nanoencapsulation of Methylene-Blue for Enhanced Skin Cancer Cell Phototoxicity and Cutaneous Penetration in Association with Sonophoresis
Photodynamic therapy (PDT) using methylene blue (MB) as a photosensitizer has emerged as an alternative treatment for skin cancers, such as squamous cell carcinoma (SCC). To increase the cutaneous penetration of the drug, some strategies are used, such as the association of nanocarriers and physical methods. Thus, herein we address the development of nanoparticles based on poly-Ɛ-caprolactone (PCL), optimized with the Box–Behnken factorial design, for topical application of MB associated with sonophoresis. The MB-nanoparticles were developed using the double emulsification-solvent evaporation technique and the optimized formulation resulted in an average size of 156.93 ± 8.27 nm, a polydispersion index of 0.11 ± 0.05, encapsulation efficiency of 94.22 ± 2.19% and zeta potential of −10.08 ± 1.12 mV. Morphological evaluation by scanning electron microscopy showed spherical nanoparticles. In vitro release studies show an initial burst compatible with the first-order mathematical model. The nanoparticle showed satisfactory generation of reactive oxygen species. The MTT assay was used to assess cytotoxicity and IC50; values of 79.84; 40.46; 22.37; 9.90 µM were obtained, respectively, for the MB-solution and the MB-nanoparticle without and with light irradiation after 2 h of incubation. Analysis using confocal microscopy showed high cellular uptake for the MB-nanoparticle. With regard to skin penetration, a higher concentration of MB was observed in the epidermis + dermis, corresponding to 9.81, 5.27 μg/cm2 in passive penetration and 24.31 and 23.81 μg/cm2 after sonophoresis, for solution-MB and nanoparticle-MB, respectively. To the best of our knowledge, this is the first report of MB encapsulation in PCL nanoparticles for application in skin cancer using PDT.
- 29 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1371
Open AccessNanoencapsulation of Methylene-Blue for Enhanced Skin Cancer Cell Phototoxicity and Cutaneous Penetration in Association with Sonophoresis
Photodynamic therapy (PDT) using methylene blue (MB) as a photosensitizer has emerged as an alternative treatment for skin cancers, such as squamous cell carcinoma (SCC). To increase the cutaneous penetration of the drug, some strategies are used, such as the association of nanocarriers and physical methods. Thus, herein we address the development of nanoparticles based on poly-Ɛ-caprolactone (PCL), optimized with the Box–Behnken factorial design, for topical application of MB associated with sonophoresis. The MB-nanoparticles were developed using the double emulsification-solvent evaporation technique and the optimized formulation resulted in an average size of 156.93 ± 8.27 nm, a polydispersion index of 0.11 ± 0.05, encapsulation efficiency of 94.22 ± 2.19% and zeta potential of −10.08 ± 1.12 mV. Morphological evaluation by scanning electron microscopy showed spherical nanoparticles. In vitro release studies show an initial burst compatible with the first-order mathematical model. The nanoparticle showed satisfactory generation of reactive oxygen species. The MTT assay was used to assess cytotoxicity and IC50; values of 79.84; 40.46; 22.37; 9.90 µM were obtained, respectively, for the MB-solution and the MB-nanoparticle without and with light irradiation after 2 h of incubation. Analysis using confocal microscopy showed high cellular uptake for the MB-nanoparticle. With regard to skin penetration, a higher concentration of MB was observed in the epidermis + dermis, corresponding to 9.81, 5.27 μg/cm2 in passive penetration and 24.31 and 23.81 μg/cm2 after sonophoresis, for solution-MB and nanoparticle-MB, respectively. To the best of our knowledge, this is the first report of MB encapsulation in PCL nanoparticles for application in skin cancer using PDT.